NCT00124293View on ClinicalTrials.gov

Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

CompletedOBSERVATIONAL

Enrollment

63

Participants

Timeline

Start Date

October 6, 2004

Primary Completion Date

November 23, 2005

Study Completion Date

November 23, 2005

Conditions

Acquired Bleeding DisorderTrauma

Interventions

DRUG

activated recombinant human factor VII

Trial Locations (2)

08536

Novo Nordisk Investigational Site, Plainsboro

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY